Rchr
J-GLOBAL ID:202001007454567723   Update date: Apr. 14, 2024

SUGANAMI Akiko

SUGANAMI Akiko
Research field  (1): Pharmacology
Research theme for competitive and other funds  (12):
  • 2022 - 2025 LH2-Colをターゲットとする免疫チェックポイント耐性克服療法の開発
  • 2021 - 2024 インドシアニングリーン修飾リポソームを用いた小児肝がん新規治療法の確立
  • 2021 - 2024 Differential regulation of TGFR family signaling and bone and cartilage tissue regeneration
  • 2020 - 2023 人工知能による東洋医学の診断・治療に係る支援システムの創生
  • 2019 - 2022 制御性T細胞の免疫抑制機構を解除する抗Tregリポソームの創生
Show all
Papers (81):
  • Yoshiharu Okamoto, Mariko Ishizuka, Fusao Sumiyama, Hisashi Kosaka, Akiko Suganami, Yutaka Tamura, Mitsugu Sekimoto, Masaki Kaibori. Inhibitory effects and gene expression analysis of chemotherapeutic photodynamic therapy by using a liposomally formulated indocyanine green derivative. Photodiagnosis and photodynamic therapy. 2022. 39. 102961-102961
  • Kenta Shinoda, Akiko Suganami, Yasumitsu Moriya, Masamichi Yamashita, Tsutomu Tanaka, Akane S Suzuki, Hiroshi Suito, Yasunori Akutsu, Kengo Saito, Yoko Shinozaki, et al. Indocyanine green conjugated phototheranostic nanoparticle for photodiagnosis and photodynamic therapy. Photodiagnosis and photodynamic therapy. 2022. 39. 103041-103041
  • Iori Okura, Nanae Hasuoka, Kanaho Senoo, Akiko Suganami, Keijo Fukushima, John W Regan, Masato Mashimo, Toshihiko Murayama, Yutaka Tamura, Hiromichi Fujino. The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2. Pharmacological reports : PR. 2021. 73. 3. 946-953
  • Akira Morita, Takao Namiki, Toshiya Nakaguchi, Kazunari Murai, Yuki Watanabe, Michimi Nakamura, Yohei Kawasaki, Yuki Shiko, Yutaka Tamura, Akiko Suganami, et al. Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study. Evidence-Based Complementary and Alternative Medicine. 2021. 2021. 1-9
  • Yoshifumi Ohno, Ruirong Yi, Akiko Suganami, Yutaka Tamura, Akio Matsumoto, Shoji Matsumoto, Kengo Saito, Hiroshi Shirasawa. CCL299, a Benzimidazole Derivative Induces G1 Phase Arrest and Apoptosis in Cancer Cells. Anticancer research. 2021. 41. 2. 699-706
more...
MISC (53):
more...
Patents (7):
  • 近赤外線の波長特性を利用した非侵襲性医療装置
  • 抗癌剤
  • 抗癌剤
  • リポソーム複合体
  • 抗癌剤
more...
Professional career (1):
  • 医学博士
Association Membership(s) (3):
情報計算化学生物学会 ,  日本免疫学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page